In Brief:
Among single-level spine procedures, in which neuromonitoring is used in approximately 13% nationally, its use is controversial. Using retrospective data, we demonstrate questionable benefit of neuromonitoring in these cases, despite significantly increased payments. On a state level, we also show significant variation in the use of neuromonitoring.
